awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q27003304-F40297D5-5F61-428B-90BB-F414396DA192
Q27003304-F40297D5-5F61-428B-90BB-F414396DA192
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27003304-F40297D5-5F61-428B-90BB-F414396DA192
Incidence and risk of sorafenib-induced hypertension: a systematic review and meta-analysis
P2860
Q27003304-F40297D5-5F61-428B-90BB-F414396DA192
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27003304-F40297D5-5F61-428B-90BB-F414396DA192
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6be09557a0a882a8cd3dc7841b1676682252c44e
P2860
Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.